Xbrane Working Towards Q2 2025 US Ranibizumab Approval

Plan Follows April CRL, Addition Of New US Marketing Partner

Sprinter on starting blocks With 2025 text
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products